HDT Bio Corp.
16Patents
16Active
16Granted
63Portfolio score
Filing activity: Nov 10, 2021 → Mar 21, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11318213B2 | Compositions and methods for delivery of RNA | Emerging Cross-Sectional Technologies | 10 | Active |
| US11376335B2 | RNA-lipid nanoparticle complexes of viral RNA polymerase region and SARS-CoV-2 spike protein region | Emerging Cross-Sectional Technologies | 9 | Active |
| US11458209B2 | Compositions and methods for delivery of nucleic acid-lipid nanoparticle complexes encoding for viral RNA polymerase region and protein antigen | Emerging Cross-Sectional Technologies | 9 | Active |
| US11534497B2 | Compositions and methods for delivery of RNA | Emerging Cross-Sectional Technologies | 9 | Active |
| US11433142B2 | Compositions and methods for delivery of RNA-lipid nanoparticle complexes encoding for viral RNA polymerase region and protein antigen | Emerging Cross-Sectional Technologies | 8 | Active |
| US11752218B2 | Nucleic acid-small diameter and liquid core nanoparticle complexed compositions | Emerging Cross-Sectional Technologies | 2 | Active |
| US11648321B2 | Compositions and methods for delivery of RNA | Emerging Cross-Sectional Technologies | 1 | Active |
| US11679163B2 | Compositions and methods for delivery of RNA | Emerging Cross-Sectional Technologies | 1 | Active |
| US11648322B2 | Compositions and methods for delivery of RNA | Emerging Cross-Sectional Technologies | 1 | Active |
| US11654200B2 | Compositions and methods for delivery of RNA | Emerging Cross-Sectional Technologies | 1 | Active |
| US12233160B2 | Dried nanoparticle compositions | Chemistry; Metallurgy | 0 | Active |
| US12257299B2 | SARS-CoV-2 RNA vaccine compositions and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12133894B2 | Compositions and methods for delivery of RNA | Chemistry; Metallurgy | 0 | Active |
| US12350329B2 | RNA vaccines against infectious diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US11559584B2 | Compositions and methods for delivery of RNA | Emerging Cross-Sectional Technologies | 0 | Active |
| US11896677B2 | Compositions and methods for delivery of RNA | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.